Hafnium-Doped Prussian Blue Nanoparticles with Homologous Tumor Targeting and Magnetic Resonance Imaging Ability for Enhanced Tumor Radiotherapy via Photothermal Therapy and Hypoxia Relief
Bioconjugate Chemistry · 19.03.2025 · 36 (3) · 597-608
DOI: 10.1021/acs.bioconjchem.5c00064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 07.03.2025. Verfasst von Ye Kuang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, School of Pharmacy, Fujian Medical University, Fuzhou 350122, …. Hauptthemen laut MEDLINE: Ferrocyanides, Magnetic Resonance Imaging, Nanoparticles, Photothermal Therapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Radiotherapy (RT) continues to encounter significant obstacles such as formidable resistance, potential harm to adjacent healthy cells, and restricted effectiveness against tumors, resulting in a notable recurrence rate. Therefore, combining imaging, other treatments, and suitable enzyme activity in one nanoplatform can enhance the RT effect and reduce the damage to normal tissue. In this study, integrating hafnium in Prussian blue (PB) nanoparticles (PB NPs) provided innovative hafnium-doped PB (HPB) NPs as multifunctional radiosensitizers. The HPB NPs were enveloped by the cancer cell membrane, resulting in cancer cell membrane-camouflaged HPB (CMHPB) NPs that can specifically target homologous tumors. Moreover, owing to the inherent ability of photothermal therapy (PTT), magnetic resonance imaging (MRI), and catalase (CAT)-like activity of PB NPs, CMHPB NPs effectively overcome tumor hypoxia and realize the MRI-guided combined RT and PTT. The prepared HPB NPs possessed uniform and cubic morphology with a monodisperse size of approximately 80 nm and T1 MRI capability (r1 = 0.9309 mM-1 S-1). The HPB NPs showed reliable PTT efficiency and CAT-like activity in vitro and in vivo. Guided by MRI, the CMHPB NPs can be precisely delivered to the tumor region for combined RT and PTT for targeted destruction of tumor cells, significantly inhibiting tumor growth. The innovative multifunctional CMHPB NPs can be used for MRI-guided RT and PTT, which address the key challenges of RT and provide a viable strategy for enhancing tumor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
- CAS Key Laboratory for Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou 215123, China.
- Fujian Key Laboratory of Pollution Control & Resource Reuse, Fuzhou 350122, China.
- Laboratory Animal Center, Fujian Medical University, Fuzhou 350122, China.
ORCID-Profile: Ye Kuang, Changmai Chen, Wei Chen
Förderung
- Natural Science Foundation of Fujian Province
- National Natural Science Foundation of China
Zitieren
APA
Kuang, Y., Chen, Y., Liu, X., Liu, B., Duan, Y., Hong, C., Yan, J., Liu, R., Zhuang, Y., Chen, C., & Chen, W. (2025). Hafnium-Doped Prussian Blue Nanoparticles with Homologous Tumor Targeting and Magnetic Resonance Imaging Ability for Enhanced Tumor Radiotherapy via Photothermal Therapy and Hypoxia Relief. Bioconjugate Chemistry, 36(3), 597-608. https://doi.org/10.1021/acs.bioconjchem.5c00064
Vancouver
Kuang Y, Chen Y, Liu X, Liu B, Duan Y, Hong C, et al. Hafnium-Doped Prussian Blue Nanoparticles with Homologous Tumor Targeting and Magnetic Resonance Imaging Ability for Enhanced Tumor Radiotherapy via Photothermal Therapy and Hypoxia Relief. Bioconjugate Chemistry. 2025;36(3):597-608. doi:10.1021/acs.bioconjchem.5c00064
BibTeX
@article{Kuang2025,
author = {Kuang, Ye and Chen, Yufang and Liu, Xinying and Liu, Baohui and Duan, Yu and Hong, Chaowei and Yan, Jincong and Liu, Renpin and Zhuang, Yubin and Chen, Changmai and Chen, Wei},
title = {Hafnium-Doped Prussian Blue Nanoparticles with Homologous Tumor Targeting and Magnetic Resonance Imaging Ability for Enhanced Tumor Radiotherapy via Photothermal Therapy and Hypoxia Relief},
journal = {Bioconjugate Chemistry},
year = {2025},
volume = {36},
number = {3},
pages = {597--608},
doi = {10.1021/acs.bioconjchem.5c00064}
}
EUVIMED